etidronate

etidronate

 [e″tĭ-dro´nāt]
a bone calcium regulator used as the disodium salt in the treatment of symptomatic osteitis deformans, for the prevention of heterotopic ossification due to spinal cord injury or following total hip replacement, and for the treatment of hypercalcemia associated with malignancy. It is also used in bone scanning, complexed with technetium 99m.

etidronate

A drug used to treat OSTEOPOROSIS and PAGET'S DISEASE of bone. A brand name is Didronel.
References in periodicals archive ?
Bisphosphonates are mainly of two sub classes, non Nitrogen containing like Etidronate, Clodronate, Tiludronate and Nitrogen containing bisphosphonates Pamidronate, Nerid-ronate, Olpadronate, Alendronate, Ibandronate, Risedronate.
bisphosphonates (alendronate, etidronate, ibandronate,
Ibandronate has previously been approved for postmenopausal osteoporosis in the US.[46] In vitro studies [47] have demonstrated that nitrogen-containing bisphosphonates (alendronate, pamidronate, ibandronate, zoledronate, and risedronate) showed an approximately 10,000-fold greater potency than nonnitrogen-containing drugs (clodronate and etidronate).
Tenders are invited for Procurement of sodium etidronate (aquacid - 1054)
Adrenolate (Fosomax), etidronate (Didronel) and zoledronic acid (Zometa) are the three most commonly-prescribed bisphosphonates.
Multiple treatment approaches with diltiazem, disodium etidronate, probenecid, colchicine, minocycline, low-dose warfarin, and intralesional adrenal steroids have been explored, but no standard treatment has convincingly prevented or reduced calcinosis.
Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study.
[15] One such approach is by inhibiting the conjugative DNA relaxase with bisphosphonates like clodronate and etidronate. [15] Targeting similar relaxases, other compounds too have shown potential like EDTA and Sulbactomax.
have reported that cyclic etidronate seems to prevent osteoporosis induced by prednisone treatment in patients with primary biliary cirrhosis (92).
Several therapies have been excluded from the update, including calcitonin, which is no longer widely used for osteoporosis treatment, and etidronate and pamidronate, neither of which are FDA-approved for the prevention of fractures or treatment of osteoporosis.
Effect of etidronate on three-dimensional trabecular structure in ovariectomized or sciatic neurectomized rats.
Similarly, it no longer addresses the use of etidronate or pamidronate, which are not approved by the Food and Drug Administration for this indication.